Research map: Keluoxin inhibits the progression of Diabetic Kidney Disease via TNF-α/IKKβ/IκBα/NF-κB p65 signaling pathway

Back to the article

Papers in this map

  1. Pattern Recognition Receptors and Inflammation · Osamu Takeuchi · 2010 · 8943 citations · Cited by this paper
  2. Responses of Regulator of G Protein Signaling Proteins and Circadian Clock Components to Sustained Depolarization-Induced Dedifferentiation in MIN6 β-Cells · 2025 · Related
  3. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy · Vlado Perkovic · 2019 · 6222 citations · Cited by this paper
  4. Diabetic Foot Syndrome · 2025 · Related
  5. Dapagliflozin in Patients with Chronic Kidney Disease · Hiddo J.L. Heerspink · 2020 · 5532 citations · Cited by this paper
  6. Pilot study: transduction of primary paraganglioma chromaffin tumour cells with inducible c-MYC drives cell proliferation · 2026 · Related
  7. The NLRP3 inflammasome: molecular activation and regulation to therapeutics · Karen V. Swanson · 2019 · 4883 citations · Cited by this paper
  8. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care · 2025 · Related
  9. TGF-β: the master regulator of fibrosis · Xiao‐Ming Meng · 2016 · 3605 citations · Cited by this paper
  10. Serum Carcinoembryonic Antigen, Carbohydrate Antigen, Neuron-specificEnolase and Lipid Profile to Predict the Occurrence, Pathological Grading andMetastasis of Pancreatic Neuroendocrine Tumors · 2026 · Related
  11. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes · George L. Bakris · 2020 · 2886 citations · Cited by this paper
  12. Diabetes and Pregnancy · 2025 · Related
  13. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study · Hui Yu · 2020 · 2186 citations · Cited by this paper
  14. Diabetes Mellitus and the Heart · 2026 · Related
  15. Changes in Diabetes-Related Complications in the United States, 1990–2010 · Edward W. Gregg · 2014 · 1751 citations · Cited by this paper
  16. Obesity and Diabetes · 2026 · Related
  17. Cellular and molecular mechanisms of renal fibrosis · Youhua Liu · 2011 · 1464 citations · Cited by this paper
  18. Acute Cold Exposure Improves Glucose Tolerance and Induces Beta-Cell Secretion Response Linked to Lipid Utilization in Young Male with Obesity · 2025 · Related
  19. TNF biology, pathogenic mechanisms and emerging therapeutic strategies · George D. Kalliolias · 2015 · 1449 citations · Cited by this paper
  20. Sudomotor Dysfunction in Fibrocalculous Pancreatic Diabetes: Clinical Insights From Electrochemical Skin Conductance Testing · 2026 · Related
  21. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis · Rajiv Agarwal · 2021 · 1298 citations · Cited by this paper
  22. Regulation and Function of IKK and IKK-Related Kinases · Hans Häcker · 2006 · 1278 citations · Cited by this paper
  23. Metabolism of inflammation limited by AMPK and pseudo-starvation · Luke A.J. O'Neill · 2013 · 1154 citations · Cited by this paper
  24. Death by TNF: a road to inflammation · Geert Loo · 2022 · 934 citations · Cited by this paper
  25. The IKK Complex, a Central Regulator of NF- B Activation · Alain Israël · 2009 · 866 citations · Cited by this paper
  26. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials · Suetonia C. Palmer · 2021 · 695 citations · Cited by this paper
  27. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management · Guoyi Tang · 2021 · 374 citations · Cited by this paper
  28. Molecular pathways that drive diabetic kidney disease · Samer Mohandes · 2023 · 342 citations · Cited by this paper
  29. Return to homeostasis: downregulation of NF-κB responses · Jürgen Ruland · 2011 · 325 citations · Cited by this paper
  30. Pharmacological Effects of Astragaloside IV: A Review · Yutong Liang · 2023 · 199 citations · Cited by this paper
  31. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway · Huimin Yang · 2019 · 194 citations · Cited by this paper
  32. Single-cell transcriptomics–based MacSpectrum reveals macrophage activation signatures in diseases · Chuan Li · 2019 · 154 citations · Cited by this paper
  33. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression · Dingkun Gui · 2013 · 144 citations · Cited by this paper
  34. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease · Jia Fu · 2022 · 134 citations · Cited by this paper
  35. What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances · Kimio Watanabe · 2022 · 90 citations · Cited by this paper
  36. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD · Sankar Dass Navaneethan · 2017 · 80 citations · Cited by this paper
  37. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF-κB pathway under high glucose conditions · Li Sun · 2014 · 72 citations · Cited by this paper
  38. Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation · Hui Feng · 2021 · 55 citations · Cited by this paper
  39. Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFα in 3T3‐L1 adipocytes · Boren Jiang · 2008 · 48 citations · Cited by this paper

Source: OpenAlex (CC0)